These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7797946)

  • 1. Seroprevalence of human T cell lymphotropic virus type II infection, with or without human immunodeficiency virus type 1 coinfection, among US intravenous drug users.
    Briggs NC; Battjes RJ; Cantor KP; Blattner WA; Yellin FM; Wilson S; Ritz AL; Weiss SH; Goedert JJ
    J Infect Dis; 1995 Jul; 172(1):51-8. PubMed ID: 7797946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USA.
    Lee HH; Weiss SH; Brown LS; Mildvan D; Shorty V; Saravolatz L; Chu A; Ginzburg HM; Markowitz N; Des Jarlais DC
    J Infect Dis; 1990 Aug; 162(2):347-52. PubMed ID: 2373871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTLV-I/II seroprevalence and HIV/HTLV coinfection among U.S. intravenous drug users.
    Cantor KP; Weiss SH; Goedert JJ; Battjes RJ
    J Acquir Immune Defic Syndr (1988); 1991; 4(5):460-7. PubMed ID: 2016683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of HTLV-I and HTLV-II among a cohort of HIV-infected women and women at risk for HIV infection. Women's Interagency HIV Study.
    Telzak EE; Hershow R; Kalish LA; Hardy WD; Zuckerman E; Levine A; Delapenha R; DeHovitz J; Greenblatt RM; Anastos K
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):513-8. PubMed ID: 9859966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T-lymphotropic virus (HTLV I-II) infection among patients in an inner-city emergency department.
    Kelen GD; DiGiovanna TA; Lofy L; Junkins E; Stein A; Sivertson KT; Lairmore M; Quinn TC
    Ann Intern Med; 1990 Sep; 113(5):368-72. PubMed ID: 2382919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T-cell lymphotropic virus 1/2 and human immunodeficiency virus antibodies identification among transactional sex workers and drug users in the Dominican Republic.
    Paulino-Ramirez R; Tapia L; Ruiz-Matuk C; Charow R; Budhwani H; Routy JP
    Trans R Soc Trop Med Hyg; 2019 Jun; 113(6):293-297. PubMed ID: 30892643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroepidemiology and clinical aspects of human T-cell lymphotropic virus type I/II infection in a cohort of intravenous drug users in New York City.
    Brown LS; Chu A; Allain JP; Lee H; Cerney M; Nemoto T
    N Y State J Med; 1991 Mar; 91(3):93-7. PubMed ID: 2047026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection with human T lymphotropic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans.
    Wiktor SZ; Cannon RO; Atkinson WL; Lutz B; Hook EW; Blattner WA; Quinn TC
    J Infect Dis; 1992 May; 165(5):920-4. PubMed ID: 1569344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection?
    Khabbaz RF; Hartel D; Lairmore M; Horsburgh CR; Schoenbaum EE; Roberts B; Hartley TM; Friedland G
    J Infect Dis; 1991 Feb; 163(2):252-6. PubMed ID: 1988509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T cell lymphotropic virus types I and II in intravenous drug users in San Francisco: risk factors associated with seropositivity.
    Feigal E; Murphy E; Vranizan K; Bacchetti P; Chaisson R; Drummond JE; Blattner W; McGrath M; Greenspan J; Moss A
    J Infect Dis; 1991 Jul; 164(1):36-42. PubMed ID: 2056217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low prevalence of human T-cell leukaemia virus-I and -II infection among drug users in Amsterdam, The Netherlands.
    van den Hoek JA; Al EJ; Huisman JG; Goudsmit J; Coutinho RA
    J Med Virol; 1991 Jun; 34(2):100-3. PubMed ID: 1890409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases.
    Khabbaz RF; Onorato IM; Cannon RO; Hartley TM; Roberts B; Hosein B; Kaplan JE
    N Engl J Med; 1992 Feb; 326(6):375-80. PubMed ID: 1729620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coinfection with HIV-1 and human T-Cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS.
    Turci M; Pilotti E; Ronzi P; Magnani G; Boschini A; Parisi SG; Zipeto D; Lisa A; Casoli C; Bertazzoni U
    J Acquir Immune Defic Syndr; 2006 Jan; 41(1):100-6. PubMed ID: 16340481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging role of HTLV-I/II and HIV-1 among intravenous drug users in Detroit.
    Ognjan AF; Lewandowski CA; Belian BT; Burczak J; Markowitz N; Lee H; Saravolatz LD
    Henry Ford Hosp Med J; 1992; 40(1-2):131-5. PubMed ID: 1428966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HTLV-II among Italian intravenous drug users and hemophiliacs.
    Zanetti AR; Zehender G; Tanzi E; Galli C; Rezza G; Cargnel A; Boschini A; Mari D; Pizzocolo G; Mazzotta F
    Eur J Epidemiol; 1992 Sep; 8(5):702-7. PubMed ID: 1426170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroepidemiology of human T-cell lymphotropic virus type I/II in northeastern Brazil.
    Moreira ED; Ribeiro TT; Swanson P; Sampaio Filho C; Melo A; Brites C; Badaró R; Toedter G; Lee H; Harrington W
    J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):959-63. PubMed ID: 8315579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of HTLV-I/II and HIV-1 infection among male intravenous drug abusers in Chicago.
    Lentino JR; Pachucki CT; Schaaff DM; Schaefer MR; Holzer TJ; Heynen C; Dawson G; Dorus W
    J Acquir Immune Defic Syndr (1988); 1991; 4(9):901-9. PubMed ID: 1895212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HTLV-I/II seropositivity and death from AIDS among HIV-1 seropositive intravenous drug users.
    Page JB; Lai SH; Chitwood DD; Klimas NG; Smith PC; Fletcher MA
    Lancet; 1990 Jun; 335(8703):1439-41. PubMed ID: 1972217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased hepatitis C virus load among injection drug users infected with human immunodeficiency virus and human T lymphotropic virus type II.
    Hisada M; Chatterjee N; Zhang M; Battjes RJ; Goedert JJ
    J Infect Dis; 2003 Sep; 188(6):891-7. PubMed ID: 12964121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HTLV-II/HIV-1 coinfection and risk for progression to AIDS among intravenous drug users.
    Visconti A; Visconti L; Bellocco R; Binkin N; Colucci G; Vernocchi L; Amendola M; Ciaci D
    J Acquir Immune Defic Syndr (1988); 1993 Nov; 6(11):1228-37. PubMed ID: 7901382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.